L.S. McCarty Scientific Research & Consulting, Newmarket, Ontario, Canada.
Environ Health Perspect. 2012 Jul;120(7):927-34. doi: 10.1289/ehp.1104277. Epub 2012 Feb 17.
There is an ongoing discussion on the provenance of toxicity testing data regarding how best to ensure its validity and credibility. A central argument is whether journal peer-review procedures are superior to Good Laboratory Practice (GLP) standards employed for compliance with regulatory mandates.
We sought to evaluate the rationale for regulatory decision making based on peer-review procedures versus GLP standards.
We examined pertinent published literature regarding how scientific data quality and validity are evaluated for peer review, GLP compliance, and development of regulations.
Some contend that peer review is a coherent, consistent evaluative procedure providing quality control for experimental data generation, analysis, and reporting sufficient to reliably establish relative merit, whereas GLP is seen as merely a tracking process designed to thwart investigator corruption. This view is not supported by published analyses pointing to subjectivity and variability in peer-review processes. Although GLP is not designed to establish relative merit, it is an internationally accepted quality assurance, quality control method for documenting experimental conduct and data.
Neither process is completely sufficient for establishing relative scientific soundness. However, changes occurring both in peer-review processes and in regulatory guidance resulting in clearer, more transparent communication of scientific information point to an emerging convergence in ensuring information quality. The solution to determining relative merit lies in developing a well-documented, generally accepted weight-of-evidence scheme to evaluate both peer-reviewed and GLP information used in regulatory decision making where both merit and specific relevance inform the process.
关于如何确保毒理学测试数据的有效性和可信度,人们一直在讨论其来源。一个核心论点是,期刊同行评议程序是否优于为遵守法规要求而采用的良好实验室规范 (GLP) 标准。
我们旨在评估基于同行评议程序与 GLP 标准的监管决策的基本原理。
我们研究了有关同行评议、GLP 合规性以及法规制定如何评估科学数据质量和有效性的相关文献。
有人认为,同行评议是一种连贯一致的评估程序,为实验数据的生成、分析和报告提供了质量控制,足以可靠地确定相对价值,而 GLP 仅被视为一种跟踪过程,旨在防止研究人员的腐败。这一观点与指向同行评议过程的主观性和可变性的已发表分析并不相符。虽然 GLP 不是为了确定相对价值而设计的,但它是一种国际公认的质量保证、质量控制方法,用于记录实验过程和数据。
这两个过程都不足以完全确定相对科学的合理性。然而,同行评议过程和监管指南都发生了变化,更加清晰透明地传达了科学信息,这表明在确保信息质量方面出现了趋同的趋势。确定相对价值的解决方案在于制定一个有充分记录、普遍接受的证据权重方案,用于评估用于监管决策的同行评议和 GLP 信息,其中价值和具体相关性都为该过程提供信息。